Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,313 | 63,515 | 71,387 | 12,946 | 7,202 |
| Receivables | 558 | 203 | 251 | 150 | 184 |
| TOTAL | $59,552 | $65,544 | $74,608 | $14,764 | $8,824 |
| Non-Current Assets | |||||
| PPE Net | 118 | 128 | 139 | 149 | 149 |
| Other Non-Current Assets | 331 | 350 | 369 | 2,272 | 1,553 |
| TOTAL | $449 | $478 | $508 | $2,421 | $1,702 |
| Total Assets | $60,001 | $66,022 | $75,116 | $17,185 | $10,526 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,599 | 489 | 2,663 | 498 | 603 |
| Accrued Expenses | 3,501 | 4,446 | 4,351 | 3,079 | 2,073 |
| TOTAL | $5,199 | $5,030 | $7,105 | $3,665 | $2,676 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 257 | 283 | 308 | 845 | 1,602 |
| TOTAL | $257 | $283 | $308 | $845 | $1,602 |
| Total Liabilities | $5,456 | $5,313 | $7,413 | $4,510 | $4,278 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,835 | 17,835 | 17,835 | 17,835 | N/A |
| Common Shares | 18 | 18 | 18 | 4 | 4 |
| Retained earnings | -114,219 | -107,682 | -100,317 | -115,480 | -109,498 |
| Other shareholders' equity | 0 | 0 | 0 | 128,151 | 115,742 |
| TOTAL | $54,545 | $60,709 | $67,703 | $12,675 | $6,248 |
| Total Liabilities And Equity | $60,001 | $66,022 | $75,116 | $17,185 | $10,526 |